SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20215531
Source:
http://linkedlifedata.com/resource/pubmed/id/20215531
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0026882
,
umls-concept:C0376358
,
umls-concept:C1515021
pubmed:issue
7
pubmed:dateCreated
2010-4-2
pubmed:abstractText
Increased prostate cancer risk has been reported for BRCA mutation carriers, but BRCA-associated clinicopathologic features have not been clearly defined.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1078-0432
pubmed:author
pubmed-author:BalistreriLisaL
,
pubmed-author:BhatiaJasmineJ
,
pubmed-author:EasthamJames AJA
,
pubmed-author:FineSamson WSW
,
pubmed-author:GallagherDavid JDJ
,
pubmed-author:GaudetMia MMM
,
pubmed-author:KirchhoffTomasT
,
pubmed-author:KleinRobert JRJ
,
pubmed-author:MorrisMichael JMJ
,
pubmed-author:NortonLarryL
,
pubmed-author:OffitKennethK
,
pubmed-author:PalProdiptoP
,
pubmed-author:ReuterVictorV
,
pubmed-author:RobsonMark EME
,
pubmed-author:ScardinoPeter TPT
,
pubmed-author:ScherHoward IHI
,
pubmed-author:StadlerZsofiaZ
,
pubmed-author:VoraKinjalK
,
pubmed-author:ZelefskyMichaelM
pubmed:copyrightInfo
Copyright 2010 AACR.
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2115-21
pubmed:meshHeading
pubmed-meshheading:20215531-Adenocarcinoma
,
pubmed-meshheading:20215531-Adult
,
pubmed-meshheading:20215531-Aged
,
pubmed-meshheading:20215531-Aged, 80 and over
,
pubmed-meshheading:20215531-Case-Control Studies
,
pubmed-meshheading:20215531-Gene Frequency
,
pubmed-meshheading:20215531-Genes, BRCA1
,
pubmed-meshheading:20215531-Genes, BRCA2
,
pubmed-meshheading:20215531-Genetic Predisposition to Disease
,
pubmed-meshheading:20215531-Germ-Line Mutation
,
pubmed-meshheading:20215531-Heterozygote Detection
,
pubmed-meshheading:20215531-Humans
,
pubmed-meshheading:20215531-Male
,
pubmed-meshheading:20215531-Middle Aged
,
pubmed-meshheading:20215531-Odds Ratio
,
pubmed-meshheading:20215531-Prostatic Neoplasms
,
pubmed-meshheading:20215531-Risk Factors
pubmed:year
2010
pubmed:articleTitle
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
pubmed:affiliation
Clinical Genetics Service, Department of Medicine, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't